Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HLF | hg38_v1_chr17_+_55267719_55267816 | 0.63 | 1.0e-04 | Click! |
TEF | hg38_v1_chr22_+_41367269_41367333 | 0.11 | 5.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_7784251 Show fit | 3.06 |
ENST00000377532.8
ENST00000377541.5 |
period circadian regulator 3 |
|
chr1_+_7784411 Show fit | 2.90 |
ENST00000613533.4
ENST00000614998.4 |
period circadian regulator 3 |
|
chr19_-_40850442 Show fit | 2.49 |
ENST00000301141.10
|
cytochrome P450 family 2 subfamily A member 6 |
|
chr3_+_186666003 Show fit | 2.12 |
ENST00000232003.5
|
histidine rich glycoprotein |
|
chr10_-_80289647 Show fit | 1.88 |
ENST00000372213.8
|
methionine adenosyltransferase 1A |
|
chr7_-_31340678 Show fit | 1.71 |
ENST00000297142.4
|
neuronal differentiation 6 |
|
chr15_-_82952683 Show fit | 1.59 |
ENST00000450735.7
ENST00000304231.12 |
homer scaffold protein 2 |
|
chr6_-_46491431 Show fit | 1.57 |
ENST00000371374.6
|
regulator of calcineurin 2 |
|
chr6_+_131573219 Show fit | 1.44 |
ENST00000356962.2
ENST00000368087.8 ENST00000673427.1 ENST00000640973.1 |
arginase 1 |
|
chr18_+_35041387 Show fit | 1.35 |
ENST00000538170.6
ENST00000300249.10 ENST00000588910.5 |
microtubule associated protein RP/EB family member 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.0 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.8 | 2.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.4 | 2.5 | GO:0051012 | microtubule sliding(GO:0051012) |
0.6 | 2.3 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.5 | 2.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.5 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 1.8 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 1.8 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 1.8 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.4 | 1.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 3.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 2.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 2.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 2.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 2.1 | GO:0036019 | endolysosome(GO:0036019) |
0.1 | 1.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 1.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 5.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 3.8 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.5 | 2.3 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 2.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 2.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 1.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 1.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 1.8 | GO:0002162 | dystroglycan binding(GO:0002162) nitric-oxide synthase binding(GO:0050998) |
0.0 | 1.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 1.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 2.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.2 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 3.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 1.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 1.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 1.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |